278 related articles for article (PubMed ID: 35373184)
1. The Role of
Jayasinghe MK; Lee CY; Tran TTT; Tan R; Chew SM; Yeo BZJ; Loh WX; Pirisinu M; Le MTN
Front Digit Health; 2022; 4():838590. PubMed ID: 35373184
[TBL] [Abstract][Full Text] [Related]
2. An artificial intelligence-assisted physiologically-based pharmacokinetic model to predict nanoparticle delivery to tumors in mice.
Chou WC; Chen Q; Yuan L; Cheng YH; He C; Monteiro-Riviere NA; Riviere JE; Lin Z
J Control Release; 2023 Sep; 361():53-63. PubMed ID: 37499908
[TBL] [Abstract][Full Text] [Related]
3. Predicting Nanoparticle Delivery to Tumors Using Machine Learning and Artificial Intelligence Approaches.
Lin Z; Chou WC; Cheng YH; He C; Monteiro-Riviere NA; Riviere JE
Int J Nanomedicine; 2022; 17():1365-1379. PubMed ID: 35360005
[TBL] [Abstract][Full Text] [Related]
4. Statistical prediction of nanoparticle delivery: from culture media to cell.
Brown MR; Hondow N; Brydson R; Rees P; Brown AP; Summers HD
Nanotechnology; 2015 Apr; 26(15):155101. PubMed ID: 25797791
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticles in drug delivery: mechanism of action, formulation and clinical application towards reduction in drug-associated nephrotoxicity.
Cooper DL; Conder CM; Harirforoosh S
Expert Opin Drug Deliv; 2014 Oct; 11(10):1661-80. PubMed ID: 25054316
[TBL] [Abstract][Full Text] [Related]
6. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
[TBL] [Abstract][Full Text] [Related]
7. Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine.
Sousa de Almeida M; Susnik E; Drasler B; Taladriz-Blanco P; Petri-Fink A; Rothen-Rutishauser B
Chem Soc Rev; 2021 May; 50(9):5397-5434. PubMed ID: 33666625
[TBL] [Abstract][Full Text] [Related]
8. Artificial Intelligence and Machine Learning in Computational Nanotoxicology: Unlocking and Empowering Nanomedicine.
Singh AV; Ansari MHD; Rosenkranz D; Maharjan RS; Kriegel FL; Gandhi K; Kanase A; Singh R; Laux P; Luch A
Adv Healthc Mater; 2020 Sep; 9(17):e1901862. PubMed ID: 32627972
[TBL] [Abstract][Full Text] [Related]
9. A high-throughput bioimaging study to assess the impact of chitosan-based nanoparticle degradation on DNA delivery performance.
Gomes CP; Varela-Moreira A; Leiro V; Lopes CDF; Moreno PMD; Gomez-Lazaro M; Pêgo AP
Acta Biomater; 2016 Dec; 46():129-140. PubMed ID: 27686038
[TBL] [Abstract][Full Text] [Related]
10. Predicting coated-nanoparticle drug release systems with perturbation-theory machine learning (PTML) models.
Santana R; Zuluaga R; Gañán P; Arrasate S; Onieva E; González-Díaz H
Nanoscale; 2020 Jul; 12(25):13471-13483. PubMed ID: 32613998
[TBL] [Abstract][Full Text] [Related]
11. A mathematical model to predict nanomedicine pharmacokinetics and tumor delivery.
Dogra P; Butner JD; Ruiz Ramírez J; Chuang YL; Noureddine A; Jeffrey Brinker C; Cristini V; Wang Z
Comput Struct Biotechnol J; 2020; 18():518-531. PubMed ID: 32206211
[TBL] [Abstract][Full Text] [Related]
12. Effects of cartilage-targeting moieties on nanoparticle biodistribution in healthy and osteoarthritic joints.
Brown SB; Wang L; Jungels RR; Sharma B
Acta Biomater; 2020 Jan; 101():469-483. PubMed ID: 31586725
[TBL] [Abstract][Full Text] [Related]
13. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
Foffi G; Pastore A; Piazza F; Temussi PA
Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the in vitro nanoparticle-cell interactions via a smoothing-splines mixed-effects model.
Dogruoz E; Dayanik S; Budak G; Sabuncuoglu I
Artif Cells Nanomed Biotechnol; 2016 May; 44(3):800-10. PubMed ID: 25962529
[TBL] [Abstract][Full Text] [Related]
15. Dynamic nanoparticle assemblies.
Wang L; Xu L; Kuang H; Xu C; Kotov NA
Acc Chem Res; 2012 Nov; 45(11):1916-26. PubMed ID: 22449243
[TBL] [Abstract][Full Text] [Related]
16. Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation.
Shi J; Xiao Z; Kamaly N; Farokhzad OC
Acc Chem Res; 2011 Oct; 44(10):1123-34. PubMed ID: 21692448
[TBL] [Abstract][Full Text] [Related]
17. Molecular imaging with theranostic nanoparticles.
Jokerst JV; Gambhir SS
Acc Chem Res; 2011 Oct; 44(10):1050-60. PubMed ID: 21919457
[TBL] [Abstract][Full Text] [Related]
18. Active Cellular and Subcellular Targeting of Nanoparticles for Drug Delivery.
Nag OK; Delehanty JB
Pharmaceutics; 2019 Oct; 11(10):. PubMed ID: 31635367
[TBL] [Abstract][Full Text] [Related]
19. A Comprehensive Study on Nanoparticle Drug Delivery to the Brain: Application of Machine Learning Techniques.
Yousfan A; Al Rahwanji MJ; Hanano A; Al-Obaidi H
Mol Pharm; 2024 Jan; 21(1):333-345. PubMed ID: 38060692
[TBL] [Abstract][Full Text] [Related]
20. Surface engineering of inorganic nanoparticles for imaging and therapy.
Nam J; Won N; Bang J; Jin H; Park J; Jung S; Jung S; Park Y; Kim S
Adv Drug Deliv Rev; 2013 May; 65(5):622-48. PubMed ID: 22975010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]